当前位置： SCI文献检索 > GENE THERAPY期刊下所有文献 > Excessive activated T-cell proliferation after anti-CD19 CAR T-cell therapy.

Excessive activated T-cell proliferation after anti-CD19 CAR T-cell therapy.

Abstract：

:Excessive activated T-cell proliferation was observed in vivo in one patient after an anti-CD19-chimeric antigen receptor (CAR) T-cell infusion. The patient, who had chemotherapy refractory and CD19+ diffuse large B-cell lymphoma (DLBCL), received an anti-CD19 CAR T-cell infusion following conditioning chemotherapy (fludarabine/cyclophosphamide). The lymphocyte count in the peripheral blood (PB) increased to 77 × 109/L on day 13 post infusion, and the proportion of CD8+ actived T cells was 93.06% of the lymphocytes. Then, the patient suffered from fever and hypoxaemia. Significant increases in serum cytokine, lactate dehydrogenase, aspartate aminotransferase (AST), alanine transaminase (ALT), and glutamic-oxalacetic transaminase (γ-GT) levels were observed. A high-throughput sequencing analysis for T-cell receptors (TCRs) and whole-genome sequencing were used to explore the mechanisms underlying this excessive T-cell proliferation. TCR diversity was demonstrated, but no special gene mutation was found. The patient was found to be infected with the John Cunningham polyomavirus (JCV). It cannot be ruled out the bystander activation pathway induced by JCV infections related the excessive activated T-cell proliferation. Although the clinical and laboratory data do not fully explain the reason for excessive T-cell proliferation after the anti-CD19 CAR T-cell infusion, the risk of this type of toxicity should be emphasized. This study was registered at www.clinicaltrials.gov as NCT01864889.

journal_name

Gene Ther

journal_title

Gene therapy

authors

Zhang WY,Liu Y,Wang Y,Nie J,Guo YL,Wang CM,Dai HR,Yang QM,Wu ZQ,Han WD

doi

10.1038/s41434-017-0001-8

subject

Has Abstract

pub_date

2018-06-01 00:00:00

pages

198-204

issue

3

eissn

0969-7128

issn

1476-5462

pii

10.1038/s41434-017-0001-8

journal_volume

25

pub_type

杂志文章

相关文献

GENE THERAPY文献大全
  • Gene therapy progress and prospects: therapeutic angiogenesis for ischemic cardiovascular disease.

    abstract：:During the past decade, both in vitro and in vivo studies have provided new insights into the cellular and molecular mechanisms that govern angiogenesis and arteriogenesis. However, therapeutic angiogenesis clinical trials using recombinant protein or gene therapy formulations of single angiogenic growth factors have ...

    journal_title：Gene therapy

    pub_type： 杂志文章,评审

    doi：10.1038/sj.gt.3302953

    authors： Vincent KA,Jiang C,Boltje I,Kelly RA

    更新日期：2007-05-01 00:00:00

  • Efficient gene delivery to human and rodent islets with double-stranded (ds) AAV-based vectors.

    abstract：:Transplantation of allogeneic pancreatic islets is an effective approach to treat type 1 diabetes. To bypass the need for systemic administration of immunosuppression drugs following transplantation, approaches to genetically modify allogeneic islets to express anti-inflammatory, immunosuppressive, or antiapoptotic pr...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：10.1038/sj.gt.3302530

    authors： Rehman KK,Wang Z,Bottino R,Balamurugan AN,Trucco M,Li J,Xiao X,Robbins PD

    更新日期：2005-09-01 00:00:00

  • Effect of tolerance induction to immunodominant T-cell epitopes of Sendai virus on gene expression following repeat administration to lung.

    abstract：:Sendai virus (SeV) is able to transfect airway epithelial cells efficiently in vivo. However, as with other viral vectors, repeated administration leads to reduced gene expression. We have investigated the impact of inducing immunological tolerance to immunodominant T-cell epitopes on gene expression following repeate...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：10.1038/sj.gt.3302677

    authors： Griesenbach U,Boyton RJ,Somerton L,Garcia SE,Ferrari S,Owaki T,Ya-Fen Z,Geddes DM,Hasegawa M,Altmann DM,Alton EW

    更新日期：2006-03-01 00:00:00

  • Modulation of feeding by chronic rAAV expression of a relaxin-3 peptide agonist in rat hypothalamus.

    abstract：:Relaxin-3 is a neuropeptide that is abundantly expressed by discrete brainstem neuron populations that broadly innervate forebrain areas rich in the relaxin-3 G-protein-coupled-receptor, RXFP3. Acute and subchronic central administration of synthetic relaxin-3 or an RXFP3-selective agonist peptide, R3/I5, increase fee...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：10.1038/gt.2012.83

    authors： Ganella DE,Callander GE,Ma S,Bye CR,Gundlach AL,Bathgate RA

    更新日期：2013-07-01 00:00:00

  • AAV delivery of mineralocorticoid receptor shRNA prevents progression of cold-induced hypertension and attenuates renal damage.

    abstract：UNLABELLED:The aim of this study was to determine the effect of RNA interference inhibition of mineralocorticoid receptor (MR) on cold-induced hypertension (CIH) and renal damage. Recombinant adeno-associated virus (AAV) carrying short hairpin small interference (si)RNA for MR (AAV.MR-shRNA) was constructed and tested ...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：10.1038/sj.gt.3302768

    authors： Wang X,Skelley L,Cade R,Sun Z

    更新日期：2006-07-01 00:00:00

  • Co-expression of p21(Waf1/Cip1) in adenovirus vectors improves expression of a second transgene.

    abstract：:First-generation adenoviral (Ad) vectors are frequently used vectors for experimental and clinical gene transfer. Earlier it has been shown that parallel overexpression of the cell cycle regulator p21(Waf1/Cip1) (p21) or antiapoptotic bcl-2 from a second vector reduces cytotoxicity and improves transgene expression. H...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：10.1038/gt.2009.2

    authors： Schumacher A,Horvat S,Woischwill C,Wolff G,Witt C

    更新日期：2009-04-01 00:00:00

  • Injection of IL-12 gene-transduced dendritic cells into mouse liver tumor lesions activates both innate and acquired immunity.

    abstract：:Dendritic cell (DC)-based vaccines have been applied clinically in the setting of advanced-stage cancer. To date, the clinical efficacy of these vaccines has been limited, possibly owing to the impairment of transferred DC function in cancer-bearing patients. In this study, we examined the therapeutic efficacy of inte...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：10.1038/sj.gt.3302941

    authors： Tatsumi T,Takehara T,Yamaguchi S,Sasakawa A,Miyagi T,Jinushi M,Sakamori R,Kohga K,Uemura A,Ohkawa K,Storkus WJ,Hayashi N

    更新日期：2007-06-01 00:00:00

  • Efficient adventitial gene delivery to rabbit carotid artery with cationic polymer-plasmid complexes.

    abstract：:Different lipids and cationic polymers were tested in vitro for their ability to transfect rabbit aortic smooth muscle cells and human endothelial cells with lacZ marker gene. Toxicity of the complexes was evaluated with MTT assay. Selected plasmid-polymer complexes with different charge ratios were then tested for in...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：10.1038/sj.gt.3300800

    authors： Turunen MP,Hiltunen MO,Ruponen M,Virkamäki L,Szoka FC Jr,Urtti A,Ylä-Herttuala S

    更新日期：1999-01-01 00:00:00

  • Why commercialization of gene therapy stalled; examining the life cycles of gene therapy technologies.

    abstract：:This report examines the commercialization of gene therapy in the context of innovation theories that posit a relationship between the maturation of a technology through its life cycle and prospects for successful product development. We show that the field of gene therapy has matured steadily since the 1980s, with th...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：10.1038/gt.2013.72

    authors： Ledley FD,McNamee LM,Uzdil V,Morgan IW

    更新日期：2014-02-01 00:00:00

  • Alpha-1-antitrypsin expression in the lung is increased by airway delivery of gene-transfected macrophages.

    abstract：:Inadequate antiprotease activity in the lungs due to alpha-1-antitrypsin (A1AT) deficiency is a factor of early-onset emphysema. We propose a new approach to gene therapy that involves the intratracheal delivery of macrophages expressing human A1AT (hA1AT). Recombinant adeno-associated virus (rAAV) plasmids encoding t...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：10.1038/sj.gt.3302121

    authors： Zhang D,Wu M,Nelson DE,Pasula R,Martin WJ 2nd

    更新日期：2003-12-01 00:00:00

  • Anti-angiogenic therapy increases intratumoral adenovirus distribution by inducing collagen degradation.

    abstract：:Conditionally replicating adenoviruses (CRAd) are a promising class of gene therapy agents that can overcome already known glioblastoma (GBM) resistance mechanisms but have limited distribution upon direct intratumoral (i.t.) injection. Collagen bundles in the extracellular matrix (ECM) have an important role in inhib...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：10.1038/gt.2012.42

    authors： Thaci B,Ulasov IV,Ahmed AU,Ferguson SD,Han Y,Lesniak MS

    更新日期：2013-03-01 00:00:00

  • Fibroblasts modulate cardiomyocyte excitability: implications for cardiac gene therapy.

    abstract：:In an earlier study exploring the potential of gene transfer to repair myocardial conduction defects, we observed that myotubes, generated by forced expression of MyoD, exhibit reduced excitability when also modified to express connexin43 (Cx43). We hypothesized that this effect was caused by gap junction-mediated cou...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：10.1038/sj.gt.3302813

    authors： Kizana E,Ginn SL,Smyth CM,Boyd A,Thomas SP,Allen DG,Ross DL,Alexander IE

    更新日期：2006-11-01 00:00:00

  • Gene therapy in autoimmune, demyelinating disease of the central nervous system.

    abstract：:Multiple sclerosis (MS) is an immune-mediated disease of the central nervous system (CNS), where suspected autoimmune attack causes nerve demyelination and progressive neurodegeneration and should benefit from both anti-inflammatory and neuroprotective strategies. Although neuroprotection strategies are relatively une...

    journal_title：Gene therapy

    pub_type： 杂志文章,评审

    doi：10.1038/sj.gt.3302025

    authors： Baker D,Hankey DJ

    更新日期：2003-05-01 00:00:00

  • Folate receptor mediated DNA delivery into tumor cells: potosomal disruption results in enhanced gene expression.

    abstract：:We have used a particular folate receptor, which is overexpressed in tumor cells, for targeted DNA delivery into these cell types. This folate receptor internalizes folate through caveolae by a process named potocytosis, which is distinct from endocytosis, through clathrin-coated pits. When folate conjugated to poly-L...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：

    authors： Gottschalk S,Cristiano RJ,Smith LC,Woo SL

    更新日期：1994-05-01 00:00:00

  • RNAi-mediated gene silencing in tumour tissue using replication-competent retroviral vectors.

    abstract：:RNAi represents a powerful technology to specifically downregulate the expression of target genes. For cancer research and therapy, an efficient in vivo delivery system is supposed to distribute RNAi to all tumour cells upon systemic administration. We present replication-competent murine leukaemia virus (MLV) vectors...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：10.1038/gt.2011.48

    authors： Schaser T,Wrede C,Duerner L,Sliva K,Cichutek K,Schnierle B,Buchholz CJ

    更新日期：2011-10-01 00:00:00

  • Generation of human TRIM5alpha mutants with high HIV-1 restriction activity.

    abstract：:Rhesus macaque tripartite motif (TRIM)5alpha potently inhibits early stages of human immunodeficiency virus (HIV)-1 replication, while the human orthologue has little effect on this virus. We used PCR-based random mutagenesis to construct a large library of human TRIM5alpha variants containing mutations in the PRYSPRY...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：10.1038/gt.2010.40

    authors： Pham QT,Bouchard A,Grütter MG,Berthoux L

    更新日期：2010-07-01 00:00:00

  • The immunogenicity of virus-derived 2A sequences in immunocompetent individuals.

    abstract：:Genetic engineering of T cells for adoptive immunotherapy in cancer patients has shown significant promise. To ensure optimal antitumor activity and safety, the simultaneous expression of multiple genes is frequently required, and short viral-derived 2A sequences are increasingly preferred for this purpose. Concerns e...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：10.1038/gt.2013.25

    authors： Arber C,Abhyankar H,Heslop HE,Brenner MK,Liu H,Dotti G,Savoldo B

    更新日期：2013-09-01 00:00:00

  • Highly efficient multipotent differentiation of human periodontal ligament fibroblasts induced by combined BMP4 and hTERT gene transfer.

    abstract：:Because periodontal ligament (PDL) cells are reported to contain progenitor or stem cell populations, they are considered a beneficial cell source for clinical periodontal regeneration. Both bone morphogenetic protein 4 (BMP4) and human telomerase reverse transcriptase (hTERT) have essential roles in the modulation of...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：10.1038/gt.2010.158

    authors： Mi HW,Lee MC,Fu E,Chow LP,Lin CP

    更新日期：2011-05-01 00:00:00

  • Herpesvirus microRNAs for use in gene therapy immune-evasion strategies.

    abstract：:Transplantation of allogeneic cells as well as of genetically corrected autologous cells are potent approaches to restore cellular functions in patients suffering from genetic diseases. The recipient's immune responses against non-self-antigens may compromise the survival of the grafted cells. Recipients of the graft ...

    journal_title：Gene therapy

    pub_type： 杂志文章,评审

    doi：10.1038/gt.2017.37

    authors： Bots STF,Hoeben RC

    更新日期：2017-07-01 00:00:00

  • Gene doping detection: evaluation of approach for direct detection of gene transfer using erythropoietin as a model system.

    abstract：:As clinical gene therapy has progressed toward realizing its potential, concern over misuse of the technology to enhance performance in athletes is growing. Although 'gene doping' is banned by the World Anti-Doping Agency, its detection remains a major challenge. In this study, we developed a methodology for direct de...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：10.1038/gt.2010.49

    authors： Baoutina A,Coldham T,Bains GS,Emslie KR

    更新日期：2010-08-01 00:00:00

  • Differentiation-specific enhancer activity in transduced keratinocytes: a model for epidermal gene therapy.

    abstract：:HaCaT cells, a spontaneously immortalised, nontumorigenic keratinocyte line, were used as a more amenable model than primary keratinocytes for ex vivo-mediated gene transfer. These cells were transduced with retroviral vectors containing the factor IX cDNA under the control of a cytomegaloviral (CMV) promoter/enhancer...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：10.1038/sj.gt.3300591

    authors： Page SM,Brownlee GG

    更新日期：1998-03-01 00:00:00

  • Effective treatment of vascular endothelial growth factor refractory hindlimb ischemia by a mutant endothelial nitric oxide synthase gene.

    abstract：:Gene delivery of angiogenic growth factors is a promising approach for the treatment of ischemic cardiovascular diseases. However, success of this new therapeutic principle is hindered by the lack of critical understanding as to how disease pathology affects the efficiency of gene delivery and/or the downstream signal...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：10.1038/sj.gt.3302781

    authors： Qian HS,Liu P,Huw LY,Orme A,Halks-Miller M,Hill SM,Jin F,Kretschmer P,Blasko E,Cashion L,Szymanski P,Vergona R,Harkins R,Yu J,Sessa WC,Dole WP,Rubanyi GM,Kauser K

    更新日期：2006-09-01 00:00:00

  • Positive and negative regulation of gene expression in eukaryotic cells with an inducible transcriptional regulator.

    abstract：:To facilitate the understanding of the complex process of target gene expression and its control, we report a modified inducible system for activation or repression of target gene expression in response to an exogenously administered compound. The main component of this inducible system is a chimeric transcriptional a...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：10.1038/sj.gt.3300402

    authors： Wang Y,Xu J,Pierson T,O'Malley BW,Tsai SY

    更新日期：1997-05-01 00:00:00

  • Antigen design enhances the immunogenicity of Semliki Forest virus-based therapeutic human papillomavirus vaccines.

    abstract：:Cellular immunity against cancer can be achieved with viral vector- and DNA-based immunizations. In preclinical studies, cancer vaccines are very potent, but in clinical trials these potencies are not achieved yet. Thus, a rational approach to improve cancer vaccines is warranted. We previously demonstrated that the r...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：10.1038/gt.2015.24

    authors： Ip PP,Boerma A,Walczak M,Oosterhuis K,Haanen JB,Schumacher TN,Nijman HW,Daemen T

    更新日期：2015-07-01 00:00:00

  • Restoration of all dystrophin protein interactions by functional domains in trans does not rescue dystrophy.

    abstract：:Rescue of dystrophic skeletal muscle in mdx and utrophin/dystrophin-deficient (dko) mouse models by reintroduction of dystrophin has validated gene therapy as a potential therapeutic approach for Duchenne muscular dystrophy. However, the size of the dystrophin gene exceeds the capacity of adeno-associated viral (AAV) ...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：10.1038/sj.gt.3302686

    authors： Gardner KL,Kearney JA,Edwards JD,Rafael-Fortney JA

    更新日期：2006-05-01 00:00:00

  • Potent antitumor activity of oncolytic adenovirus-mediated SOCS1 for hepatocellular carcinoma.

    abstract：:Signal transducer and activator of transcription 3 (STAT3) is constitutively activated in diverse cancers, which contributes to the proliferation and survival of cancer cells by upregulating apoptosis inhibitors and cell cycle regulators. Suppressor of cytokine signaling 1 (SOCS1) is an important negative regulator of...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：10.1038/gt.2012.4

    authors： Liu L,Li W,Wei X,Cui Q,Lou W,Wang G,Hu X,Qian C

    更新日期：2013-01-01 00:00:00

  • Understanding lentiviral vector chromatin targeting: working to reduce insertional mutagenic potential for gene therapy.

    abstract：:Replication-deficient retroviruses have been successfully utilized as vectors, offering an efficient, stable method of therapeutic gene delivery. Many examples exist proving this mode of integrative gene transfer is both effective and safe in cultured systems and clinical trials. Along with their success, severe side ...

    journal_title：Gene therapy

    pub_type： 杂志文章,评审

    doi：10.1038/gt.2012.88

    authors： Papayannakos C,Daniel R

    更新日期：2013-06-01 00:00:00

  • Sustained expression after nonviral ocular gene transfer using mammalian promoters.

    abstract：:The CMV promoter drives high transgene expression and is one of the most commonly used promoters for gene transfer. Tissue-specific mammalian promoters provide an alternative, and it would be useful to have a system to directly compare them to viral promoters free from potential confounding vector-related effects. In ...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：10.1038/sj.gt.3302700

    authors： Kachi S,Esumi N,Zack DJ,Campochiaro PA

    更新日期：2006-05-01 00:00:00

  • MnSOD mediated by HSV vectors in the periaqueductal gray suppresses morphine withdrawal in rats.

    abstract：:Morphine appears to be the most active metabolite of heroin; therefore, the effects of morphine are important in understanding the ramifications of heroin abuse. Opioid physical dependence (withdrawal response) may have very long-lasting effects on the motivation for reward, including the incubation of cue-induced dru...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：10.1038/gt.2017.22

    authors： Iida T,Yi H,Liu S,Ikegami D,Zheng W,Liu Q,Takahashi K,Kashiwagi Y,Goins WF,Glorioso JC,Hao S

    更新日期：2017-05-01 00:00:00

  • GCV phosphates are transferred between HeLa cells despite lack of bystander cytotoxicity.

    abstract：:The role of gap junctional intercellular communication (GJIC) in bystander killing with herpes simplex virus thymidine kinase (HSV-TK) and ganciclovir (GCV) was evaluated in U251 cells expressing a dominant-negative connexin 43 cDNA (DN14), and in HeLa cells, reportedly devoid of connexin protein. These cell lines bot...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：10.1038/sj.gt.3302487

    authors： Gentry BG,Im M,Boucher PD,Ruch RJ,Shewach DS

    更新日期：2005-07-01 00:00:00